RefinedPractice
Valuing the National Clinical Assessment Service
1 April 2011
The UK’s National Clinical Assessment Service (NCAS) provides advice to NHS managers about handling performance issues involving doctors, pharmacists and dentists. This post summarises an OHE…
Value-Based Pricing: OHE Comments
23 March 2011
In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which…
Two Economists Join OHE
10 March 2011
The Office of Health Economics is pleased to announce the appointment of two Economists. Dr Yan Feng specialises in understanding what incentives affect the behaviour of…
Differential Pricing – A Win-Win Solution?
2 March 2011
Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects…
New: Priority Review Vouchers and Innovation
17 February 2011
This OHE Seminar Briefing recounts a presentation by Prof Henry Grabowski on US Priority Review Vouchers, intended to provide an incentive for the development of drugs…
New OHE Commission on Competition in the NHS
14 February 2011
Competition in the NHS is viewed as if it must either be for everything the NHS provides to patients or for nothing. Neither extreme is likely…
The Spanish Medicines Market Today
9 February 2011
Spending by Spain’s National Health Service (NHS) on pharmaceuticals was €12.1 billion in 2010. Its market for prescription medicines is among the slowest growing in Europe,…
Exploring Local NHS Decisions about Investment
4 February 2011
OHE is pleased to welcome Jamie Garside to the team. Jamie recently graduated with an MSc in health economics (with Distinction) from City University London.
Comparing Variants of Lead and Lag Time TTO
1 February 2011
OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes. Results of the second of these, advances in…